ANI Pharmaceuticals | ANIP - EPS Earnings Per Share

Stock Price
78.01
Daily Change
-1.57 -1.97%
Monthly
-0.08%
Yearly
30.04%
Q2 Forecast
76.44

ANI Pharmaceuticals reported $2.05 in EPS Earnings Per Share for its fiscal quarter ending in March of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q1 Mar/2026 2.05 1.58 1.70 May/08
FY2025Q4 Dec/2025 2.33 1.97 1.63 Feb/27
FY2025Q3 Sep/2025 2.04 1.71 1.34 Nov/07
FY2025Q2 Jun/2025 1.80 1.43 1.02 Aug/08
FY2025Q1 Mar/2025 1.70 1.12 1.21 May/09




Eps Change Date
AbbVie USD 2.65 0.06 Mar/2026
ANI Pharmaceuticals USD 2.05 0.28 Mar/2026
Assertio Holdings USD -0.03 0.01 Sep/2024
Aurora Cannabis CAD -0.64 0.36 Dec/2025
Canopy Growth CAD -0.05 0.03 Dec/2025
Eli Lilly USD 8.55 1.01 Mar/2026
Emergent BioSolutions USD -0.77 0.29 Dec/2023
Heron Therapeutics USD -0.02 0.02 Dec/2025
Hikma Pharmaceutical USD 0.65 0.12 Dec/2025
Knight Therapeutics CAD 0.13 0.22 Mar/2026
Nektar Therapeutics USD -1.35 1.17 Dec/2025
Novartis USD 1.99 0.45 Mar/2026
Omeros USD -1.12 0.37 Jun/2024
Perrigo USD 0.43 0.34 Mar/2026
Sun Pharmaceuticals INR 12.8 0.2 Dec/2025
Teva Pharmaceutical Industries USD 1.57 1.41 Mar/2026